Clark Zhang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 3
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Justin Hanes (12 shared papers)Daniel D. Lee (5 shared papers)Elizabeth Nance (5 shared papers)Jung Soo Suk (8 shared papers)Panagiotis Mastorakos (8 shared papers)Alejandro Ribeiro (5 shared papers)Qingguo Xu (1 shared paper)Benjamin S. Schuster (1 shared paper)
- Journals
- Journal of Controlled Release (4 papers)RSC Advances (2 papers)Advanced Healthcare Materials (2 papers)The FASEB Journal (1 paper)Biomaterials (1 paper)
- Partner nations
- United StatesNetherlandsPakistan
In The Last Decade
Clark Zhang
27 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 108
- Biomaterials 336
- Genetics 112
- Pharmaceutical Science 65
- Biomedical Engineering 341
- Neurology 38
Countries citing papers authored by Clark Zhang
This map shows the geographic impact of Clark Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark Zhang more than expected).
Fields of papers citing papers by Clark Zhang
This network shows the impact of papers produced by Clark Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark Zhang. The network helps show where Clark Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Clark Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 219 | |
| 2 | 2019 | 172 | |
| 3 | 2017 | 106 | |
| 4 | 2017 | 104 | |
| 5 | 2015 | 69 | |
| 6 | 2014 | 58 | |
| 7 | 2017 | 44 | |
| 8 | 2015 | 43 | |
| 9 | 2018 | 40 | |
| 10 | 2021 | 33 | |
| 11 | 2019 | 31 | |
| 12 | 2017 | 25 | |
| 13 | 2021 | 14 | |
| 14 | 2022 | 11 | |
| 15 | 2016 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2018 | 5 | |
| 20 | 2019 | 4 |
About Clark Zhang
Clark Zhang is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Electrical and Electronic Engineering and Genetics, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Ultrasound and Hyperthermia Applications (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Glioma Diagnosis and Treatment (3 papers), Virus-based gene therapy research (3 papers), Cerebrospinal fluid and hydrocephalus (2 papers) and Advanced MIMO Systems Optimization (2 papers). The work is most often cited by research in Biomaterials (336 citations), Genetics (112 citations), Pharmaceutical Science (65 citations), Biomedical Engineering (341 citations) and Neurology (38 citations). Clark Zhang has collaborated with scholars based in United States, Netherlands and Pakistan. Frequent co-authors include Justin Hanes, Daniel D. Lee, Elizabeth Nance, Jung Soo Suk, Panagiotis Mastorakos, Alejandro Ribeiro, Qingguo Xu, Benjamin S. Schuster, Mark Eisen and Luiz F. O. Chamon. Their work appears in journals such as Journal of Controlled Release, RSC Advances, Advanced Healthcare Materials, The FASEB Journal and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.